The former chief financial officer of Archegos Capital Management was sentenced on Monday to eight years in prison over his role in the firm’s 2021 collapse, which cost Wall Street banks more ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

Novo's U.S. and Europe-listed stocks leapt. Shares of rival Eli Lilly (LLY) also rallied. 🔎 Affirm (AFRM): The "buy-now-pay-later" lender secured $750 million in funding from insurer Liberty ...

Before the open, Novo Nordisk stock jumped while Eli Lilly fell. In the phase 1b/2a clinical trial, obese and overweight patients taking 20 milligrams of the amycretin drug saw an average weight ...

Earnings Report 5.284 USD Q4 2024 Earnings Release 02/06/2025 Earnings Report 4.894 USD Q1 2025 Earnings Release 05/01/2025 Earnings Report 5.682 USD Q2 2025 Earnings Release 08/07/2025 Earnings ...

Ryan Lucas covers the Justice Department for NPR. He focuses on the national security side of the Justice beat, including counterterrorism, counterintelligence and transnational repression.

Dave Lucas is the weekday anchor of WJLA 24/7's news at noon and the afternoon editions between 2 p.m. and 5 p.m. He joined WJLA 24/7 as one of the original anchors in 1991, when it launched ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50 ...

Notable gainers during the session included Apple (AAPL), Eli Lilly (LLY), and Walmart (WMT), demonstrating market resilience in certain sectors despite the tech-focused decline. To watch more ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...